P-084: Bone marrow of patients post ASCT, but not chemotherapy consolidation, contains expanded T cell receptor clonotypes that are present at diagnosis: results from the Phase 2 CARDAMON studyKane Foster, Kwee Yong, Daria Galas‐Filipowicz et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 0
P-228: ASCT does not benefit patients who are MRD negative following induction therapy: updated results from the Phase 2 Cardamon studyKwee Yong, Rakesh Popat, William W. Wilson et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 0
P-390 The differentiation and expansion of T cell clonotypes in the bone marrow following ASCT: insights from the Phase 2 CARDAMON studyKane Foster, Kwee Yong, Karthik Ramasamy et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0